Key facts
- Lattice Medical’s last known valuation is $11.0M (Oct 2022).
- It has raised $55.6M; the latest was Later Stage VC ($50.4M) in Oct 2025.
- Notable investors include Bpifrance, European Innovation Council, MedTech Innovator, La French Tech, European Regional Development Fund (Brandenburg) — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Lattice Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Lattice Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lattice Medical
Operator of a medical device company intended to help manufacture and design soft tissue reconstruction devices for breast reconstruction. The company specializes in implants for breast reconstruction after cancer that help in personalized reconstruction with a single surgery, enabling health professionals to reduce surgery time, minimize invasiveness, and minimize pain.
- Sector
- Healthcare
- HQ
- Loos, France
- Founded
- 2017
- Employees
- 37
- Website
- lattice-medical.com/
- Ownership
- Privately Held (backing)
Lattice Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lattice Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lattice Medical in its N-PORT filings yet. We sweep new filings monthly.